TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: PRO--Patient Reported Outcomes: compliance with post screening recommendations
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: AUCt of Zastaprazan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Zastaprazan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline cerebellar inhibition (CBI) input output curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Inadvertent perioperative hypothermia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progesterone metabolites (levels in plasma)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Itch intensity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 2-year brain metastasis-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Composite of death from cardiovascular causes or first hospitalization for heart failure
Endpoint domain: Mortality/survival
Primary endpoint: incidence of cardiac mortality
Endpoint domain: Mortality/survival
Primary endpoint: number of worsening of heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in functional capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported cognitive functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Carer-reported cognitive functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Self-reported neurobehavioral functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Carer-reported neurobehavioral functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of elderly people remained at home
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Oxygen reserve index (ORI) alarming time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Pemphigus Disease Activity Index (PDAI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Autoimmune Bullous Skin Disorder Intensity Score (ABSIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Total Post-operative Opioid Requirements
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants Adherent to Endocrine Therapy and CVD Medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of Participants Adherent to Endocrine Therapy and CVD Medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy of Modified Atkin's Diet therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Portal vein pulsatility index variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous use of both arms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jebsen Taylor Test of Hand Function (JTTHF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal Muscle Mitochondrial Respiration State 3 Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bronchoalveolar Lavage (BAL) evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Signal-to-noise ratio of focal electroretinography signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in tactile sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in respiratory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in sleep onset
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in total sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in sleep stages
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: successful insertion of ureteral access sheath
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Respiratory muscles thickness in centimeter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Respiratory muscles thickening fraction (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sputum volume in milliliter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of Ideal Body Weight Percentage (IBW%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of MRI signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rapid Entire Body Assessment (REBA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve for the Last Measurable Concentration (AUClast) of VX-993
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve From the Time of Dosing Extrapolated to Infinity (AUC0-inf) of VX-993
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BIS50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in neuropsychiatric symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Latency Period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uric acid/SOD ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of subjects with any solicited local injection site adverse events (AE) within 7 days after each vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of subjects with any solicited systemic AE within 7 days after each vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of subjects with any Serious Adverse Events (SAE) within 6 months after last vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Depression Anxiety Stress Scale (DASS-Depression)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Illness Intrusiveness Ratings Scale (IIRS)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Diagnostic model accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognostic model accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in body composition index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in sperm count/concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: number of eligible patients for immunotherapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 24-week levonorgestrel area under the concentration-time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 12-week medroxyprogesterone acetate AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Extent of caries around tooth margin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Frequency of CMV reactivation
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of treatment effect of PPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risky sexual behaviors
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Successful performance after sacrospinous fixation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: New root caries lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Restorations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Medication discrepancy
Endpoint domain: Adverse events/effects
Primary endpoint: N2 amplitudes of FVEPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean change in subjectively perceived lower back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics in Cerebrospinal Fluid (CSF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the Curve (AUC) of total plasma CHF6001
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum of Concentration (Cmax) of total plasma CHF6001
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Haemodynamically significant CAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in 1-minute sit to stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intracranial Progression-Free Survival (PFSi)
Endpoint domain: Mortality/survival
Primary endpoint: Overall Progression-Free Survival (PFSo)
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline in the mRTSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood and urine samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Falls Effectiveness Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: myometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Blood glucose levels at the time of reperfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Modified Rankin scale at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Severity of immune-related adverse events (irAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Performance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of Hospitalisation or Fatal Outcome
Endpoint domain: Mortality/survival
Primary endpoint: Association between facial expression-derived objective valence and self-reported subjective mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Association between facial expression-derived objective mood and self-reported subjective mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Home monitoring of health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Asthma evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Molecular characterization of particles in exhaled air
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Molecular characterization of samples from the lung
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Complication rate of ambulatory surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Family Empowerment Scale (FES)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Brief Pain Inventory (BPI) severity index
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Brief Pain Inventory (BPI) interference index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in cognition composite score from baseline to 12-weeks
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in emotion score from baseline to 12-weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of scheduled intervention sessions attended
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: True presence and absence of malignancy in each lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of NODAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Toxicity of 13-cis-retinoic Acid
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with fatty liver disease among obese patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of subjects with fatty liver disease among non-obese patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Markers of severity (CD177)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Markers of severity (S100A8&S100A12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Survivors Who Agree to Participate
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Interventions Sessions Completed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants Satisfied with the Intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lithotripsy speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG correlates of inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: H-score for diagnosis of lymphoma-associated HLH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cytokine production changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Transcriptional profile changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Completeness rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adequate cleanliness rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Aggregate adherence to quality measures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Surgical incision healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Scar scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Functional movement assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive-Negative Affect Scale (PANAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Actigraphy - sleep onset latency (SOL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Change in Actigraphy - total sleep time (TST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Children's Communication Checklist-2
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Brain connectivity of frontotemporal regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum C reactive protein (CRP) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative hemolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Area Under the Concentration-Time Curve (AUC) of PBI-200 from time zero to infinity [AUC(0-inf)]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Concentration [C(max)]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent Terminal Elimination Half-life [t(1/2)]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pitch Decoding Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frequency-Following Response Magnitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cortical Phase-Locking Limits of Frequency-Following Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in illicit opioid use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Presence of 3rd and 4th degree perineal damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Visual Analogua Scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Menstrual attitude
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Modified Progression Free Survival (mPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Number of uninterrupted sleep-wake cycling (SWC)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Receptor operating characteristic (ROC) curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet-thrombus formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Picture naming
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Recurrence of symptoms
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: postoperative hemorrhage
Endpoint domain: Adverse events/effects
Endpoint subdomain: null
Primary endpoint: Percentage of Participants With Clinically significant CMV Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Number of severe bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Standard alcoholic drinks per week
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Timeline Followback (TLFB) heavy drinking days
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient-rated PTSD Checklist for DSM-5 (PCL-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in Executive Abilities Composite Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in flow mediated dilatation (FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of appropriate weekly dose
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of days on therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Biomarker - Contactin 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarker - Contactin 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generation of patient derived xenografts (PDX) and organoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: pain in lower back
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: core muscles stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cut-off values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of Distal Emboli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mTICI score of ≥2b
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who go into remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin Temperature (ST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Success rate 1 year after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of device implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain assessed by Numerical Rating Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events/complications
Endpoint domain: Adverse events/effects
Primary endpoint: Ability to discriminate durations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative Remifentanil consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intraoperative consumption of the halogenated agent (sevoflurane)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sensitivity to detect cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity to detect cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive predictive value (PPV) to detect cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative predictive value (NPV) to detect cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biopsy pathological reclassification rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute phase reactants levels in pneumonia patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total perioperative analgesia consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Readiness of hospital discharge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: relative change in uptake of [18F]F-AraG in tumor lesions and lymphoid organs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: baseline [18F]F-AraG uptake and tumor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes